3Gunton J E, Stiel J, Clifton-Bligh P et al. Prevelence of positive antineutrophilic cytoplasmic antibody(ANCA) in patients receiving anti-thyroid medication [J]. Eur J Endocr,2000;142:587-590.
4Merkel P A. Drugs associated with vasculitis [J]. Curr Opin Rheumatol, 1998;10:45-50.
5Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W et al. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease [J]. J Med Assoc Thai, 2002;85(4):S1295-S1301.
6Chastain M A, Russo G G, Boh E E et al. Propythiouracil hypersensitivity: report of two patients with vasculitis and review of the literature [J]. J Am Acad Dermatol,1999;41:757-764.
7Kudoh Y, Kuroda S, Shimamoto K et al. propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophilic cytoplasmic antibodies [J]. Clin Nephrol,1997;48(1):41-43.
8Nakamori Y, Tominaga T, Inoue Y et al. Propylthiouracil(PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase(MPO-ANCA) [J]. Intern Med, 2003;42(6):529-533.
9Hillon S S, Singh D, Doe N et al. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil [J]. Chest,1999;116(5):1485-1488.
10Miller R M, Savige J, Nassis L et al. Antineutrophil cytoplasmic antibody(ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease [J]. Australas J Dermatol,1998;39:96-99.
